Shanghai Yitai Pharmaceutical Technology Overview

  • Founded
  • 2016
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Shanghai Yitai Pharmaceutical Technology General Information

Description

Provider of bio-pharmaceutical services intended to develop and commercialize innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The company's bio-pharmaceutical services include developing synthetic peptide analog of human parathyroid hormone-related protein (hPTHrP) which is a bone-building hormone and product for treatment of osteoporosis in both injection and trans dermal methods of administration, enabling doctors to cure their patients quickly.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 811 Huahong Business Center
  • 388 Daduhe Road No. 5
  • Shanghai, Putuo 200062
  • China
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Yitai Pharmaceutical Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shanghai Yitai Pharmaceutical Technology‘s full profile, request access.

Request a free trial